Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $356,317 | 1 | 75.7% |
| Acquisitions | $114,282 | 1 | 24.3% |
| Food and Beverage | $261.53 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $356,317 | 1 | $0 (2017) |
| Medtronic, Inc. | $114,282 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $126.20 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $78.10 | 3 | $0 (2024) |
| ABBVIE INC. | $57.23 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.25 | 4 | AstraZeneca Pharmaceuticals LP ($52.99) |
| 2023 | $152.28 | 6 | AstraZeneca Pharmaceuticals LP ($73.21) |
| 2021 | $114,282 | 1 | Medtronic, Inc. ($114,282) |
| 2017 | $356,317 | 1 | Medtronic Vascular, Inc. ($356,317) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Respiratory | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: VACCINES | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Respiratory | ||||||
| 05/26/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Respiratory | ||||||
| 05/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: VACCINES | ||||||
| 04/29/2021 | Medtronic, Inc. | TYRX (Device) | Acquisitions | Cash or cash equivalent | $114,281.84 | General |
| Category: Antibacterial Mesh | ||||||
| 08/14/2017 | Medtronic Vascular, Inc. | — | Royalty or License | Cash or cash equivalent | $356,316.70 | General |
About Dr. Daniel Lerner, M.D
Dr. Daniel Lerner, M.D is a Cardiovascular Disease healthcare provider based in Scarsdale, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1295042117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lerner, M.D has received a total of $470,860 in payments from pharmaceutical and medical device companies, with $109.25 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Royalty or License" ($356,317).
Practice Information
- Specialty Cardiovascular Disease
- Location Scarsdale, NY
- Active Since 09/13/2010
- Last Updated 09/13/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295042117
Products in Payments
- TYRX (Device) $114,282
- BREZTRI (Drug) $126.20
- SHINGRIX (Biological) $50.91
- SYNTHROID (Drug) $29.07
- VRAYLAR (Drug) $28.16
- TRELEGY ELLIPTA (Drug) $27.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Scarsdale
Dr. Srirama Kalapatapu, M.d, M.D
Cardiovascular Disease — Payments: $185,044
Dr. Anthony Mercando, Md, MD
Cardiovascular Disease — Payments: $69,054
Dr. Ari Paley, M.d, M.D
Cardiovascular Disease — Payments: $25,362
Dr. Sanjay Naik, M.d, M.D
Cardiovascular Disease — Payments: $23,287
Dr. Amit Chhabra, M.d, M.D
Cardiovascular Disease — Payments: $16,979
Dr. Howard Chester, M.d, M.D
Cardiovascular Disease — Payments: $2,207